Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
The recruitment status of this study is unknown because the information has not been verified recently.
Verified August 2004 by Corixa Corporation.
Recruitment status was Active, not recruiting
Recruitment status was Active, not recruiting
Sponsor:
Corixa Corporation
Collaborator:
GlaxoSmithKline
Information provided by:
Corixa Corporation
ClinicalTrials.gov Identifier:
NCT00022880
First received: August 15, 2001
Last updated: June 23, 2005
Last verified: August 2004
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is ongoing, but not recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |